Opthea Limited – NASDAQ:OPT
Opthea Limited stock price today
$3.41
-0.5
-12.79%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 4 hours
Opthea Limited stock price monthly change
+94.53%
month
Opthea Limited stock price quarterly change
+94.53%
quarter
Opthea Limited stock price yearly change
+30.77%
year
Opthea Limited key metrics
Market Cap | 4.56B |
Enterprise value | 45.16M |
P/E | -1.42 |
EV/Sales | 181.76 |
EV/EBITDA | -1.17 |
Price/Sales | 991.92 |
Price/Book | 4.36 |
PEG ratio | 0.01 |
EPS | -1.27 |
Revenue | 313.16K |
EBITDA | -182.23M |
Income | -172.07M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -12157.58% |
Oper. margin | -13104.93% |
Gross margin | 11.54% |
EBIT margin | -13104.93% |
EBITDA margin | -58193.17% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOpthea Limited stock price history
Opthea Limited stock forecast
Opthea Limited financial statements
| Sep 2021 | 106.11K | -26.09M | -24589.56% |
|---|---|---|---|
| Dec 2021 | 105.54K | -25.95M | -24589.53% |
| Jun 2022 | 45.63K | -55.10M | -120750.77% |
| Jun 2023 | 55.86K | -64.92M | -116205.83% |
| 2028 | 721.90M | 150.16M | 20.8% |
|---|
Analysts Price target
Financials & Ratios estimates
| Jun 2022 | 60046819 | 12.06M | 20.1% |
|---|---|---|---|
| Nov 2022 | 0 | 0 | |
| Dec 2022 | 154008347 | 97.54M | 63.33% |
| Jun 2023 | 98641319 | 104.49M | 105.93% |
| Mar 2020 | 0 | -2.19M | -2.19M |
|---|---|---|---|
| Jun 2020 | 0 | -30.94K | -47.70K |
| Jun 2022 | -61.67M | -22.10K | -57.73K |
| Jun 2023 | -50.49M | -14.77K | -965.92K |
Opthea Limited alternative data
| Nov 2023 | 24 |
|---|---|
| Dec 2023 | 24 |
| Jan 2024 | 24 |
| Feb 2024 | 24 |
| Mar 2024 | 24 |
| Apr 2024 | 24 |
| May 2024 | 24 |
| Jun 2024 | 24 |
| Jul 2024 | 24 |
Opthea Limited other data
0.50%
-1.67%
of OPT is owned by hedge funds
1.75M
-5.85M
shares is hold by hedge funds
| Insider | Compensation |
|---|---|
Ms. Karen Adams CPA (1971) Vice President of Fin. & Company Sec. | $701,330 |
Dr. Megan Baldwin M.A.I.C.D., MAICD, Ph.D. (1974) MD, Chief Executive Officer & Executive Director | $531,450 |
-
What's the price of Opthea Limited stock today?
One share of Opthea Limited stock can currently be purchased for approximately $3.41.
-
When is Opthea Limited's next earnings date?
Unfortunately, Opthea Limited's (OPT) next earnings date is currently unknown.
-
Does Opthea Limited pay dividends?
No, Opthea Limited does not pay dividends.
-
How much money does Opthea Limited make?
Opthea Limited has a market capitalization of 4.56B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 22.65% to 124.67K US dollars.
-
What is Opthea Limited's stock symbol?
Opthea Limited is traded on the NASDAQ under the ticker symbol "OPT".
-
What is Opthea Limited's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Opthea Limited?
Shares of Opthea Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Opthea Limited's key executives?
Opthea Limited's management team includes the following people:
- Ms. Karen Adams CPA Vice President of Fin. & Company Sec.(age: 54, pay: $701,330)
- Dr. Megan Baldwin M.A.I.C.D., MAICD, Ph.D. MD, Chief Executive Officer & Executive Director(age: 51, pay: $531,450)
-
How many employees does Opthea Limited have?
As Jul 2024, Opthea Limited employs 24 workers.
-
When Opthea Limited went public?
Opthea Limited is publicly traded company for more then 4 years since IPO on 16 Oct 2020.
-
What is Opthea Limited's official website?
The official website for Opthea Limited is opthea.com.
-
Where are Opthea Limited's headquarters?
Opthea Limited is headquartered at 650 Chapel Street, South Yarra, VIC.
-
How can i contact Opthea Limited?
Opthea Limited's mailing address is 650 Chapel Street, South Yarra, VIC and company can be reached via phone at +61 3 9826 0399.
Opthea Limited company profile:
Opthea Limited
opthea.comExchange:
NASDAQ
Full time employees:
33
Industry:
Biotechnology
Sector:
Healthcare
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema DME, as well as a first in class VEGF C/D inhibitors for treatment with VEGF A inhibitors for the treatment of wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.
650 Chapel Street
South Yarra, VIC 3141
South Yarra, VIC 3141
CIK: 0001815620
ISIN: US68386J2087
CUSIP: 68386J208
